Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05135845 |
Title | Combination of Capmatinib + Spartalizumab in Advanced Oesogastric Adenocarcinoma (METIMGAST) |
Acronym | METIMGAST |
Recruitment | Suspended |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Assistance Publique - Hopitaux de Paris |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | FRA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Hôpital Jean Minjoz | Besançon | 25030 | France | Details | ||
Centre François Leclerc | Dijon | France | Details | |||
Centre Léon Bérard | Lyon | 69008 | France | Details | ||
AP-HP Hôpital Saint Louis | Paris | 75010 | France | Details | ||
Hôpital Haut Lévêque | Pessac | 33604 | France | Details | ||
Institut Universitaire du Cancer | Toulouse | 31059 | France | Details | ||
Institut Gustave Roussy | Villejuif | 94805 | France | Details |